Nevertheless, a patient affected by IDH1 mutant oligodendroglioma recently showed reduced tumour-associated epilepsy after treatment with the IDH1 mutant inhibitor AG-120 (ivosidenib) [129]. Here, IDH1 is linked to oligodendroglioma.